Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Autoimmunity Reviews|April 3, 2020
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Philippe Mertz, Flora Sagez, et al.
Journal of Internal Medicine|June 28, 2023
Mouth opening in systemic sclerosis: A longitudinal analysis from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Christian Agard, et al.
Annals of the Rheumatic Diseases|May 22, 2015
Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE studyEric Hachulla, Pierre-Yves Hatron, Patrick Carpentier, et al.
The Journal of Rheumatology|January 17, 2017
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for ScreeningMaria-Grazia Lazzaroni, Ilaria Cavazzana, Enrico Colombo, et al.
Rheumatology (Oxford, England)|December 29, 2020
Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exerciseLinda Rossi-Semerano, Sylvain Breton, Luca Semerano, et al.
Rheumatology (Oxford, England)|May 11, 2021
Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patientsDan Levy, Benoit Nespola, Margherita Giannini, et al.
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Pageof 6